IMV share price logo

IMV

OTC: IMVIF

Live

as on

IMV Stock Performance

as on October 21, 2026 at 12:56 am IST

IMV share price movements today

Previous Close
-
Open
-
Volume
3.0K
Market Cap
$23.4K

IMV Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

IMV Stock Fundamentals & Key Indicators

Check IMV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.4K

EPS (TTM)

-4.41

Dividend Yield

0.00%

PE Ratio (TTM)

-0.18

Industry PE ratio

0.00

PEG Ratio

-0.02

Return On Equity TTM

-495.17%

IMV stock Key Stats

Compare market cap, revenue, PE, and other key metrics of IMV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
IMV image
IMV
NA$23.4KNA-0.180.00%0.00%

Indian Investors' Interest in IMV Stock

Search interest for IMV Stock has increased by 240% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:240% versus previous 30 day period

IMV Quarterly Profit & Loss

All numbers in Millions USD

Sep 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-11
-6
-7
-10
-11
-10
-10
-9
-8
EBITDA
-7
-6
-7
-10
-11
-10
-9
-9
-6
Interest Expense
-
0
0
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-6
-7
-10
-11
-10
-9
-8
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-6
-6
-7
-10
-11
-10
-8
-7
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

IMV Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Total Revenue
0
0
0
0
-
-
Gross Profit
0
0
0
0
0
0
Operating Income
-12
-15
-22
-35
-40
-38
EBITDA
-
-21
-19
-28
-36
-35
Interest Expense
0
1
0
0
0
-
Depreciation
-
0
0
0
0
0
Income Before Tax
-12
-16
-22
-28
-37
-36
Income Tax Expense
0
-1
-1
-1
-1
-
Net Income
-12
-21
-20
-27
-36
-36
Net Profit Margin
-324.05%
100.00%
100.00%
100.00%
0.00%
0.00%

IMV Quarterly Cash Flow

All numbers in Millions USD

Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Net Income
-8
-11
-6
-7
-10
-11
-10
-9
-8
-8
Operating Cash Flow
-6
-3
-7
-7
-9
-7
-10
-6
-9
-6
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
32
-1
2
0
23
10
0
9
1
5
Change in Cash
26
-5
-5
-7
13
2
-9
2
-9
0

IMV Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Net Income
-9
-16
-21
-23
-36
-37
Operating Cash Flow
-9
-17
-21
-24
-31
-32
Investing Cash Flow
0
-2
0
0
-1
-1
Financing Cash Flow
10
19
27
51
35
16
Change in Cash
2
-1
0
25
2
-17

About IMV

IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
OrganisationIMV
Headquarters130 Eileen Stubbs Avenue, Dartmouth, NS, B3B 2C4, CA
IndustryBiotechnology
CEOAndrew Hall

Key Management of IMV

Name

Title

Ms. Brittany Davison C.A., CPA

Corporate Secretary & Director

Mr. Stephan Fiset M.B.A., M.Sc.

Vice President of Clinical Research

Mr. Andrew Hall M.Sc.

CEO & Director

FAQs

What is IMV's market capitalisation today?

IMV market capitalisation is $0.00T as on .

How to invest in IMV Stock (IMVIF) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for IMV on INDmoney app. Click on Buy button.

What is the minimum amount required to buy IMV Stock (IMVIF) from India?

Indian investors can start investing in IMV (IMVIF) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in IMV stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .